Dapagliflozin 10 mg Tablets

Pack: 10 tablets/strip

DOSAGE: ONCE DAILY

Mode of Action

• Reversible inhibitor of sodium glucose co-transporter 2 protein
• Increase urinary excretion of excess glucose (diabetes obesity & metabolism)

Dapagliflozin reduced the rate of cardiovascular (CV) death or hospitalization for heart failure (HHF), did not adversely affect major adverse CV events and possibly reduced progression of renal disease relative to placebo in patients with established atherosclerotic CV disease (CVD) or multiple risk factors for CVD.

Indication:

• Uncontrolled Type 2 diabetes mellitus
• Diabetic patient with cardiovascular diseases